Abstract
High risk-human papillomaviruses (HPVs) are known carcinogens. Numerous reports have linked the steroid hormone estrogen, and the expression of estrogen receptors (ERs), to HPV-related cancers, although the exact nature of the interactions remains to be fully elucidated. Here we will focus on estrogen signaling and describe both pro and potentially anti-cancer effects of this hormone in HPV-positive cancers. This review will summarize: (1) cell culture-related evidence, (2) animal model evidence, and (3) clinical evidence demonstrating an interaction between estrogen and HPV-positive cancers. This comprehensive review provides insights into the potential relationship between estrogen and HPV. We suggest that estrogen may provide a potential therapeutic for HPV-related cancers, however additional studies are necessary.
Author supplied keywords
Cite
CITATION STYLE
James, C. D., Morgan, I. M., & Bristol, M. L. (2020, May 1). The relationship between estrogen-related signaling and human papillomavirus positive cancers. Pathogens. MDPI AG. https://doi.org/10.3390/pathogens9050403
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.